Eli Lilly LLY
NYSE LLY
$1,143.30 -6.79 (-0.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eli Lilly (LLY) Income from Discontinued Operations (2018 - 2019)

Updated

Eli Lilly (LLY) posted Income from Discontinued Operations of $3.68 billion for FY2019, compared with $81.4 million in FY2018.

Analysis

Eli Lilly (LLY) Income from Discontinued Operations (2018 - 2019) Analysis & Trends

  • Business Quant data shows LLY's Income from Discontinued Operations at $81.4 million in FY2018 and -$117.7 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 3.68 Bn
Dec 31, 2018 3.70 Mn
Sep 30, 2018 55.90 Mn
Jun 30, 2018 -28.30 Mn
Mar 31, 2018 50.20 Mn
API Access

Eli Lilly Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=LLY&period=max&api_key=YOUR_API_KEY